| Name | Title | Contact Details |
|---|---|---|
Regina Owens |
Director, Operations Learning and Development | Profile |
Seniorlink is a tech-enabled health services company transforming care management in the home. For over 15 years, we`ve pioneered solutions for caregivers, including our compassionate technology of Vela, and our unique in-home model of Caregiver Homes. These innovative approaches have earned Caregiver Homes recognition as the first community-based organization to receive the National Committee for Quality Assurance`s (NCQA) highest level of accreditation for Case Management. Today, we remain fully committed to caregivers, supporting them at every step with resources, advocacy and insights as they fulfill their promise to a loved one. We value your contribution to this important mission, and look forward to having you join our team.
Medical Practice Management Services is a Coeur D Alene, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Babeskin Bodycare is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
Mr. Gallagher is Senior Vice President & Chief Financial Officer at RRD International, LLC. Mr. Gallagher provides strategic, operational, and financial leadership to RRD. His primary responsibilities are planning, implementing, managing, and controlling all financial-related activities including the development of financial and operational strategies. Mr. Gallagher has over 20 years of finance experience in the biopharma industry with both multi-national corporations and commercial-stage public biotechnology companies. He has an extensive background in all areas of corporate controllership, including financial planning & analysis, cost control, management accounting, corporate administration, and systems implementation. He has supported all aspects of product development and commercialization, including the negotiation and execution of licensing and collaboration agreements with major pharma partners. Mr. Gallagher served previously as Vice President of Finance for Optimer Pharmaceuticals and, prior to that, as Senior Director of Finance and Corporate Controller for Adolor Corporation. He had a central role in the sale of both companies. Mr. Gallagher spent the first 10 years of his career with Therakos, Inc. (a Johnson & Johnson company) and Merck & Co., Inc. He received his BS in Finance from The Pennsylvania State University and is an active Certified Management Accountant (CMA).